| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 5e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |